Global Atracurium Market

Atracurium Comprehensive Study by Type (25mg, 50mg), Application (Hospital, Clinic, ASCs, Others) Players and Region - Global Market Outlook to 2028

Atracurium Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Atracurium Market?

Due to increasing instances of invasive surgeries as well as many other health related issues, significant demand will be generated for Atracurium. “Atracurium” can also be known as Atracurium besilate, Atracurium besylate, Atracurium dibesylate, Besilate d'atracurium, and Besilato de atracurio. It is a non-depolarizing neuromuscular blocking agent with comparatively shorter duration of action. Also, minimum cardiovascular effects and its lack of dependence on stable kidney function can provide competitive advantage over alternate non-depolarizing neuromuscular blocking agents. Although, overdoses of the same might cause the risk of histamine release and hypotension.

Highlights from Atracurium Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledGlaxoSmithKline Plc. (United Kingdom), HOSPIRA (United States), Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China), Jiangsu Hengrui Medicine (China), Zhejiang Xianju Pharmaceutical Co., Ltd. (China), Joshi and Company (India), Zhejiang Haisen Pharmaceutical Co. Ltd. (China), Aurobindo Pharma Limited (India), Sagent Pharmaceuticals Inc. (United States) and Alkaloids Corporation (India)


Research Analyst at AMA predicts that Asian Players will contribute to the maximum growth of Global Atracurium market throughout the forecasted period.

GlaxoSmithKline Plc. (United Kingdom), HOSPIRA (United States), Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China), Jiangsu Hengrui Medicine (China), Zhejiang Xianju Pharmaceutical Co., Ltd. (China), Joshi and Company (India), Zhejiang Haisen Pharmaceutical Co. Ltd. (China), Aurobindo Pharma Limited (India), Sagent Pharmaceuticals Inc. (United States) and Alkaloids Corporation (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biophore (India), Sinoway Industrial Co. Ltd. (China), Euticals S.p.a. (Italy) and Indukern (Spain).

Atracurium Market Segmentation:
ScopeSub-Segments
Application / End UserHospital, Clinic, ASCs and Others
Type25mg and 50mg


On the basis of geography, the market of Atracurium has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, Spain, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
More Prompt and Faster Medication as compared to other Anesthetic Medicines and Growing Research and Developments on Atracurium Treatments to Minimize Side Effects

Market Growth Drivers:
Growing Adoption of Atracurium in Healthcare Industry for Skeletal Muscle Relaxation and Favorable and Unique Metabolic Profiles for Atracurium than Tubocurarine, Metocurine, and Pancuronium

Challenges:
Highly skilled Workforce, as well as Technologically Advanced Production Techniques, are required to survive in the Global Competitive Environment and Higher Initial Investments for the Atracurium and Stringent

Restraints:
Over Dosage may Increase the Risk of Histamine Release and Cardiovascular Defects and Availability of Number of Substitutes across the Globe

Opportunities:
Produces Negligible Cumulative Effects with Repeated Doses leads to Minimal Side Effects and Releases Comparatively Lesser Histamine which will improve the Demand for Atracurium

Key Target Audience
Atracurium Manufacturers, Distributors and Suppliers, Atracurium International Traders, Pharmaceutical Industry Organizations, Hospitals & Clinics, Healthcare Equipment Manufacturers, Government Agencies and Others

Market Leaders & Development Strategies
On January 17th, 2019, Aurobindo Pharma Limited ("Aurobindo") has signed a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the United States. Acrotech Biopharma LLC which is a wholly owned subsidiary of Aurobindo Pharma USA Inc. will be acquiring the portfolio on a debt free and cash free basis.
On February 5th, 2019, GlaxoSmithKline plc, Merck KGaA, and Darmstadt have entered into a global strategic alliance to jointly develop and commercialize M7824 (bintrafusp alfa*), which is an investigational bi-functional fusion protein immunotherapy that is currently in clinical development, including potential registration studies, for multiple difficult-to-treat cancers.


Report Objectives / Segmentation Covered

By Type
  • 25mg
  • 50mg
By Application
  • Hospital
  • Clinic
  • ASCs
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Adoption of Atracurium in Healthcare Industry for Skeletal Muscle Relaxation
      • 3.2.2. Favorable and Unique Metabolic Profiles for Atracurium than Tubocurarine, Metocurine, and Pancuronium
    • 3.3. Market Challenges
      • 3.3.1. Highly skilled Workforce, as well as Technologically Advanced Production Techniques, are required to survive in the Global Competitive Environment
      • 3.3.2. Higher Initial Investments for the Atracurium and Stringent
    • 3.4. Market Trends
      • 3.4.1. More Prompt and Faster Medication as compared to other Anesthetic Medicines
      • 3.4.2. Growing Research and Developments on Atracurium Treatments to Minimize Side Effects
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Atracurium, by Type, Application and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Atracurium (Value)
      • 5.2.1. Global Atracurium by: Type (Value)
        • 5.2.1.1. 25mg
        • 5.2.1.2. 50mg
      • 5.2.2. Global Atracurium by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. ASCs
        • 5.2.2.4. Others
      • 5.2.3. Global Atracurium Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. Spain
          • 5.2.3.3.5. United Kingdom
          • 5.2.3.3.6. Netherlands
          • 5.2.3.3.7. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Atracurium (Volume)
      • 5.3.1. Global Atracurium by: Type (Volume)
        • 5.3.1.1. 25mg
        • 5.3.1.2. 50mg
      • 5.3.2. Global Atracurium by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. ASCs
        • 5.3.2.4. Others
      • 5.3.3. Global Atracurium Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. Spain
          • 5.3.3.3.5. United Kingdom
          • 5.3.3.3.6. Netherlands
          • 5.3.3.3.7. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Atracurium (Price)
      • 5.4.1. Global Atracurium by: Type (Price)
  • 6. Atracurium: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. HOSPIRA (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Jiangsu Hengrui Medicine (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zhejiang Xianju Pharmaceutical Co., Ltd. (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Joshi and Company (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zhejiang Haisen Pharmaceutical Co. Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Aurobindo Pharma Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sagent Pharmaceuticals Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Alkaloids Corporation (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Atracurium Sale, by Type, Application and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Atracurium (Value)
      • 7.2.1. Global Atracurium by: Type (Value)
        • 7.2.1.1. 25mg
        • 7.2.1.2. 50mg
      • 7.2.2. Global Atracurium by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. ASCs
        • 7.2.2.4. Others
      • 7.2.3. Global Atracurium Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. Spain
          • 7.2.3.3.5. United Kingdom
          • 7.2.3.3.6. Netherlands
          • 7.2.3.3.7. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Atracurium (Volume)
      • 7.3.1. Global Atracurium by: Type (Volume)
        • 7.3.1.1. 25mg
        • 7.3.1.2. 50mg
      • 7.3.2. Global Atracurium by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. ASCs
        • 7.3.2.4. Others
      • 7.3.3. Global Atracurium Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. Spain
          • 7.3.3.3.5. United Kingdom
          • 7.3.3.3.6. Netherlands
          • 7.3.3.3.7. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Atracurium (Price)
      • 7.4.1. Global Atracurium by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Atracurium: by Type(USD Million)
  • Table 2. Atracurium 25mg , by Region USD Million (2017-2022)
  • Table 3. Atracurium 50mg , by Region USD Million (2017-2022)
  • Table 4. Atracurium: by Application(USD Million)
  • Table 5. Atracurium Hospital , by Region USD Million (2017-2022)
  • Table 6. Atracurium Clinic , by Region USD Million (2017-2022)
  • Table 7. Atracurium ASCs , by Region USD Million (2017-2022)
  • Table 8. Atracurium Others , by Region USD Million (2017-2022)
  • Table 9. South America Atracurium, by Country USD Million (2017-2022)
  • Table 10. South America Atracurium, by Type USD Million (2017-2022)
  • Table 11. South America Atracurium, by Application USD Million (2017-2022)
  • Table 12. Brazil Atracurium, by Type USD Million (2017-2022)
  • Table 13. Brazil Atracurium, by Application USD Million (2017-2022)
  • Table 14. Argentina Atracurium, by Type USD Million (2017-2022)
  • Table 15. Argentina Atracurium, by Application USD Million (2017-2022)
  • Table 16. Rest of South America Atracurium, by Type USD Million (2017-2022)
  • Table 17. Rest of South America Atracurium, by Application USD Million (2017-2022)
  • Table 18. Asia Pacific Atracurium, by Country USD Million (2017-2022)
  • Table 19. Asia Pacific Atracurium, by Type USD Million (2017-2022)
  • Table 20. Asia Pacific Atracurium, by Application USD Million (2017-2022)
  • Table 21. China Atracurium, by Type USD Million (2017-2022)
  • Table 22. China Atracurium, by Application USD Million (2017-2022)
  • Table 23. Japan Atracurium, by Type USD Million (2017-2022)
  • Table 24. Japan Atracurium, by Application USD Million (2017-2022)
  • Table 25. India Atracurium, by Type USD Million (2017-2022)
  • Table 26. India Atracurium, by Application USD Million (2017-2022)
  • Table 27. South Korea Atracurium, by Type USD Million (2017-2022)
  • Table 28. South Korea Atracurium, by Application USD Million (2017-2022)
  • Table 29. Taiwan Atracurium, by Type USD Million (2017-2022)
  • Table 30. Taiwan Atracurium, by Application USD Million (2017-2022)
  • Table 31. Australia Atracurium, by Type USD Million (2017-2022)
  • Table 32. Australia Atracurium, by Application USD Million (2017-2022)
  • Table 33. Rest of Asia-Pacific Atracurium, by Type USD Million (2017-2022)
  • Table 34. Rest of Asia-Pacific Atracurium, by Application USD Million (2017-2022)
  • Table 35. Europe Atracurium, by Country USD Million (2017-2022)
  • Table 36. Europe Atracurium, by Type USD Million (2017-2022)
  • Table 37. Europe Atracurium, by Application USD Million (2017-2022)
  • Table 38. Germany Atracurium, by Type USD Million (2017-2022)
  • Table 39. Germany Atracurium, by Application USD Million (2017-2022)
  • Table 40. France Atracurium, by Type USD Million (2017-2022)
  • Table 41. France Atracurium, by Application USD Million (2017-2022)
  • Table 42. Italy Atracurium, by Type USD Million (2017-2022)
  • Table 43. Italy Atracurium, by Application USD Million (2017-2022)
  • Table 44. Spain Atracurium, by Type USD Million (2017-2022)
  • Table 45. Spain Atracurium, by Application USD Million (2017-2022)
  • Table 46. United Kingdom Atracurium, by Type USD Million (2017-2022)
  • Table 47. United Kingdom Atracurium, by Application USD Million (2017-2022)
  • Table 48. Netherlands Atracurium, by Type USD Million (2017-2022)
  • Table 49. Netherlands Atracurium, by Application USD Million (2017-2022)
  • Table 50. Rest of Europe Atracurium, by Type USD Million (2017-2022)
  • Table 51. Rest of Europe Atracurium, by Application USD Million (2017-2022)
  • Table 52. MEA Atracurium, by Country USD Million (2017-2022)
  • Table 53. MEA Atracurium, by Type USD Million (2017-2022)
  • Table 54. MEA Atracurium, by Application USD Million (2017-2022)
  • Table 55. Middle East Atracurium, by Type USD Million (2017-2022)
  • Table 56. Middle East Atracurium, by Application USD Million (2017-2022)
  • Table 57. Africa Atracurium, by Type USD Million (2017-2022)
  • Table 58. Africa Atracurium, by Application USD Million (2017-2022)
  • Table 59. North America Atracurium, by Country USD Million (2017-2022)
  • Table 60. North America Atracurium, by Type USD Million (2017-2022)
  • Table 61. North America Atracurium, by Application USD Million (2017-2022)
  • Table 62. United States Atracurium, by Type USD Million (2017-2022)
  • Table 63. United States Atracurium, by Application USD Million (2017-2022)
  • Table 64. Canada Atracurium, by Type USD Million (2017-2022)
  • Table 65. Canada Atracurium, by Application USD Million (2017-2022)
  • Table 66. Mexico Atracurium, by Type USD Million (2017-2022)
  • Table 67. Mexico Atracurium, by Application USD Million (2017-2022)
  • Table 68. Atracurium Sales: by Type(K Units)
  • Table 69. Atracurium Sales 25mg , by Region K Units (2017-2022)
  • Table 70. Atracurium Sales 50mg , by Region K Units (2017-2022)
  • Table 71. Atracurium Sales: by Application(K Units)
  • Table 72. Atracurium Sales Hospital , by Region K Units (2017-2022)
  • Table 73. Atracurium Sales Clinic , by Region K Units (2017-2022)
  • Table 74. Atracurium Sales ASCs , by Region K Units (2017-2022)
  • Table 75. Atracurium Sales Others , by Region K Units (2017-2022)
  • Table 76. South America Atracurium Sales, by Country K Units (2017-2022)
  • Table 77. South America Atracurium Sales, by Type K Units (2017-2022)
  • Table 78. South America Atracurium Sales, by Application K Units (2017-2022)
  • Table 79. Brazil Atracurium Sales, by Type K Units (2017-2022)
  • Table 80. Brazil Atracurium Sales, by Application K Units (2017-2022)
  • Table 81. Argentina Atracurium Sales, by Type K Units (2017-2022)
  • Table 82. Argentina Atracurium Sales, by Application K Units (2017-2022)
  • Table 83. Rest of South America Atracurium Sales, by Type K Units (2017-2022)
  • Table 84. Rest of South America Atracurium Sales, by Application K Units (2017-2022)
  • Table 85. Asia Pacific Atracurium Sales, by Country K Units (2017-2022)
  • Table 86. Asia Pacific Atracurium Sales, by Type K Units (2017-2022)
  • Table 87. Asia Pacific Atracurium Sales, by Application K Units (2017-2022)
  • Table 88. China Atracurium Sales, by Type K Units (2017-2022)
  • Table 89. China Atracurium Sales, by Application K Units (2017-2022)
  • Table 90. Japan Atracurium Sales, by Type K Units (2017-2022)
  • Table 91. Japan Atracurium Sales, by Application K Units (2017-2022)
  • Table 92. India Atracurium Sales, by Type K Units (2017-2022)
  • Table 93. India Atracurium Sales, by Application K Units (2017-2022)
  • Table 94. South Korea Atracurium Sales, by Type K Units (2017-2022)
  • Table 95. South Korea Atracurium Sales, by Application K Units (2017-2022)
  • Table 96. Taiwan Atracurium Sales, by Type K Units (2017-2022)
  • Table 97. Taiwan Atracurium Sales, by Application K Units (2017-2022)
  • Table 98. Australia Atracurium Sales, by Type K Units (2017-2022)
  • Table 99. Australia Atracurium Sales, by Application K Units (2017-2022)
  • Table 100. Rest of Asia-Pacific Atracurium Sales, by Type K Units (2017-2022)
  • Table 101. Rest of Asia-Pacific Atracurium Sales, by Application K Units (2017-2022)
  • Table 102. Europe Atracurium Sales, by Country K Units (2017-2022)
  • Table 103. Europe Atracurium Sales, by Type K Units (2017-2022)
  • Table 104. Europe Atracurium Sales, by Application K Units (2017-2022)
  • Table 105. Germany Atracurium Sales, by Type K Units (2017-2022)
  • Table 106. Germany Atracurium Sales, by Application K Units (2017-2022)
  • Table 107. France Atracurium Sales, by Type K Units (2017-2022)
  • Table 108. France Atracurium Sales, by Application K Units (2017-2022)
  • Table 109. Italy Atracurium Sales, by Type K Units (2017-2022)
  • Table 110. Italy Atracurium Sales, by Application K Units (2017-2022)
  • Table 111. Spain Atracurium Sales, by Type K Units (2017-2022)
  • Table 112. Spain Atracurium Sales, by Application K Units (2017-2022)
  • Table 113. United Kingdom Atracurium Sales, by Type K Units (2017-2022)
  • Table 114. United Kingdom Atracurium Sales, by Application K Units (2017-2022)
  • Table 115. Netherlands Atracurium Sales, by Type K Units (2017-2022)
  • Table 116. Netherlands Atracurium Sales, by Application K Units (2017-2022)
  • Table 117. Rest of Europe Atracurium Sales, by Type K Units (2017-2022)
  • Table 118. Rest of Europe Atracurium Sales, by Application K Units (2017-2022)
  • Table 119. MEA Atracurium Sales, by Country K Units (2017-2022)
  • Table 120. MEA Atracurium Sales, by Type K Units (2017-2022)
  • Table 121. MEA Atracurium Sales, by Application K Units (2017-2022)
  • Table 122. Middle East Atracurium Sales, by Type K Units (2017-2022)
  • Table 123. Middle East Atracurium Sales, by Application K Units (2017-2022)
  • Table 124. Africa Atracurium Sales, by Type K Units (2017-2022)
  • Table 125. Africa Atracurium Sales, by Application K Units (2017-2022)
  • Table 126. North America Atracurium Sales, by Country K Units (2017-2022)
  • Table 127. North America Atracurium Sales, by Type K Units (2017-2022)
  • Table 128. North America Atracurium Sales, by Application K Units (2017-2022)
  • Table 129. United States Atracurium Sales, by Type K Units (2017-2022)
  • Table 130. United States Atracurium Sales, by Application K Units (2017-2022)
  • Table 131. Canada Atracurium Sales, by Type K Units (2017-2022)
  • Table 132. Canada Atracurium Sales, by Application K Units (2017-2022)
  • Table 133. Mexico Atracurium Sales, by Type K Units (2017-2022)
  • Table 134. Mexico Atracurium Sales, by Application K Units (2017-2022)
  • Table 135. Atracurium: by Type(USD/Units)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Atracurium: by Type(USD Million)
  • Table 147. Atracurium 25mg , by Region USD Million (2023-2028)
  • Table 148. Atracurium 50mg , by Region USD Million (2023-2028)
  • Table 149. Atracurium: by Application(USD Million)
  • Table 150. Atracurium Hospital , by Region USD Million (2023-2028)
  • Table 151. Atracurium Clinic , by Region USD Million (2023-2028)
  • Table 152. Atracurium ASCs , by Region USD Million (2023-2028)
  • Table 153. Atracurium Others , by Region USD Million (2023-2028)
  • Table 154. South America Atracurium, by Country USD Million (2023-2028)
  • Table 155. South America Atracurium, by Type USD Million (2023-2028)
  • Table 156. South America Atracurium, by Application USD Million (2023-2028)
  • Table 157. Brazil Atracurium, by Type USD Million (2023-2028)
  • Table 158. Brazil Atracurium, by Application USD Million (2023-2028)
  • Table 159. Argentina Atracurium, by Type USD Million (2023-2028)
  • Table 160. Argentina Atracurium, by Application USD Million (2023-2028)
  • Table 161. Rest of South America Atracurium, by Type USD Million (2023-2028)
  • Table 162. Rest of South America Atracurium, by Application USD Million (2023-2028)
  • Table 163. Asia Pacific Atracurium, by Country USD Million (2023-2028)
  • Table 164. Asia Pacific Atracurium, by Type USD Million (2023-2028)
  • Table 165. Asia Pacific Atracurium, by Application USD Million (2023-2028)
  • Table 166. China Atracurium, by Type USD Million (2023-2028)
  • Table 167. China Atracurium, by Application USD Million (2023-2028)
  • Table 168. Japan Atracurium, by Type USD Million (2023-2028)
  • Table 169. Japan Atracurium, by Application USD Million (2023-2028)
  • Table 170. India Atracurium, by Type USD Million (2023-2028)
  • Table 171. India Atracurium, by Application USD Million (2023-2028)
  • Table 172. South Korea Atracurium, by Type USD Million (2023-2028)
  • Table 173. South Korea Atracurium, by Application USD Million (2023-2028)
  • Table 174. Taiwan Atracurium, by Type USD Million (2023-2028)
  • Table 175. Taiwan Atracurium, by Application USD Million (2023-2028)
  • Table 176. Australia Atracurium, by Type USD Million (2023-2028)
  • Table 177. Australia Atracurium, by Application USD Million (2023-2028)
  • Table 178. Rest of Asia-Pacific Atracurium, by Type USD Million (2023-2028)
  • Table 179. Rest of Asia-Pacific Atracurium, by Application USD Million (2023-2028)
  • Table 180. Europe Atracurium, by Country USD Million (2023-2028)
  • Table 181. Europe Atracurium, by Type USD Million (2023-2028)
  • Table 182. Europe Atracurium, by Application USD Million (2023-2028)
  • Table 183. Germany Atracurium, by Type USD Million (2023-2028)
  • Table 184. Germany Atracurium, by Application USD Million (2023-2028)
  • Table 185. France Atracurium, by Type USD Million (2023-2028)
  • Table 186. France Atracurium, by Application USD Million (2023-2028)
  • Table 187. Italy Atracurium, by Type USD Million (2023-2028)
  • Table 188. Italy Atracurium, by Application USD Million (2023-2028)
  • Table 189. Spain Atracurium, by Type USD Million (2023-2028)
  • Table 190. Spain Atracurium, by Application USD Million (2023-2028)
  • Table 191. United Kingdom Atracurium, by Type USD Million (2023-2028)
  • Table 192. United Kingdom Atracurium, by Application USD Million (2023-2028)
  • Table 193. Netherlands Atracurium, by Type USD Million (2023-2028)
  • Table 194. Netherlands Atracurium, by Application USD Million (2023-2028)
  • Table 195. Rest of Europe Atracurium, by Type USD Million (2023-2028)
  • Table 196. Rest of Europe Atracurium, by Application USD Million (2023-2028)
  • Table 197. MEA Atracurium, by Country USD Million (2023-2028)
  • Table 198. MEA Atracurium, by Type USD Million (2023-2028)
  • Table 199. MEA Atracurium, by Application USD Million (2023-2028)
  • Table 200. Middle East Atracurium, by Type USD Million (2023-2028)
  • Table 201. Middle East Atracurium, by Application USD Million (2023-2028)
  • Table 202. Africa Atracurium, by Type USD Million (2023-2028)
  • Table 203. Africa Atracurium, by Application USD Million (2023-2028)
  • Table 204. North America Atracurium, by Country USD Million (2023-2028)
  • Table 205. North America Atracurium, by Type USD Million (2023-2028)
  • Table 206. North America Atracurium, by Application USD Million (2023-2028)
  • Table 207. United States Atracurium, by Type USD Million (2023-2028)
  • Table 208. United States Atracurium, by Application USD Million (2023-2028)
  • Table 209. Canada Atracurium, by Type USD Million (2023-2028)
  • Table 210. Canada Atracurium, by Application USD Million (2023-2028)
  • Table 211. Mexico Atracurium, by Type USD Million (2023-2028)
  • Table 212. Mexico Atracurium, by Application USD Million (2023-2028)
  • Table 213. Atracurium Sales: by Type(K Units)
  • Table 214. Atracurium Sales 25mg , by Region K Units (2023-2028)
  • Table 215. Atracurium Sales 50mg , by Region K Units (2023-2028)
  • Table 216. Atracurium Sales: by Application(K Units)
  • Table 217. Atracurium Sales Hospital , by Region K Units (2023-2028)
  • Table 218. Atracurium Sales Clinic , by Region K Units (2023-2028)
  • Table 219. Atracurium Sales ASCs , by Region K Units (2023-2028)
  • Table 220. Atracurium Sales Others , by Region K Units (2023-2028)
  • Table 221. South America Atracurium Sales, by Country K Units (2023-2028)
  • Table 222. South America Atracurium Sales, by Type K Units (2023-2028)
  • Table 223. South America Atracurium Sales, by Application K Units (2023-2028)
  • Table 224. Brazil Atracurium Sales, by Type K Units (2023-2028)
  • Table 225. Brazil Atracurium Sales, by Application K Units (2023-2028)
  • Table 226. Argentina Atracurium Sales, by Type K Units (2023-2028)
  • Table 227. Argentina Atracurium Sales, by Application K Units (2023-2028)
  • Table 228. Rest of South America Atracurium Sales, by Type K Units (2023-2028)
  • Table 229. Rest of South America Atracurium Sales, by Application K Units (2023-2028)
  • Table 230. Asia Pacific Atracurium Sales, by Country K Units (2023-2028)
  • Table 231. Asia Pacific Atracurium Sales, by Type K Units (2023-2028)
  • Table 232. Asia Pacific Atracurium Sales, by Application K Units (2023-2028)
  • Table 233. China Atracurium Sales, by Type K Units (2023-2028)
  • Table 234. China Atracurium Sales, by Application K Units (2023-2028)
  • Table 235. Japan Atracurium Sales, by Type K Units (2023-2028)
  • Table 236. Japan Atracurium Sales, by Application K Units (2023-2028)
  • Table 237. India Atracurium Sales, by Type K Units (2023-2028)
  • Table 238. India Atracurium Sales, by Application K Units (2023-2028)
  • Table 239. South Korea Atracurium Sales, by Type K Units (2023-2028)
  • Table 240. South Korea Atracurium Sales, by Application K Units (2023-2028)
  • Table 241. Taiwan Atracurium Sales, by Type K Units (2023-2028)
  • Table 242. Taiwan Atracurium Sales, by Application K Units (2023-2028)
  • Table 243. Australia Atracurium Sales, by Type K Units (2023-2028)
  • Table 244. Australia Atracurium Sales, by Application K Units (2023-2028)
  • Table 245. Rest of Asia-Pacific Atracurium Sales, by Type K Units (2023-2028)
  • Table 246. Rest of Asia-Pacific Atracurium Sales, by Application K Units (2023-2028)
  • Table 247. Europe Atracurium Sales, by Country K Units (2023-2028)
  • Table 248. Europe Atracurium Sales, by Type K Units (2023-2028)
  • Table 249. Europe Atracurium Sales, by Application K Units (2023-2028)
  • Table 250. Germany Atracurium Sales, by Type K Units (2023-2028)
  • Table 251. Germany Atracurium Sales, by Application K Units (2023-2028)
  • Table 252. France Atracurium Sales, by Type K Units (2023-2028)
  • Table 253. France Atracurium Sales, by Application K Units (2023-2028)
  • Table 254. Italy Atracurium Sales, by Type K Units (2023-2028)
  • Table 255. Italy Atracurium Sales, by Application K Units (2023-2028)
  • Table 256. Spain Atracurium Sales, by Type K Units (2023-2028)
  • Table 257. Spain Atracurium Sales, by Application K Units (2023-2028)
  • Table 258. United Kingdom Atracurium Sales, by Type K Units (2023-2028)
  • Table 259. United Kingdom Atracurium Sales, by Application K Units (2023-2028)
  • Table 260. Netherlands Atracurium Sales, by Type K Units (2023-2028)
  • Table 261. Netherlands Atracurium Sales, by Application K Units (2023-2028)
  • Table 262. Rest of Europe Atracurium Sales, by Type K Units (2023-2028)
  • Table 263. Rest of Europe Atracurium Sales, by Application K Units (2023-2028)
  • Table 264. MEA Atracurium Sales, by Country K Units (2023-2028)
  • Table 265. MEA Atracurium Sales, by Type K Units (2023-2028)
  • Table 266. MEA Atracurium Sales, by Application K Units (2023-2028)
  • Table 267. Middle East Atracurium Sales, by Type K Units (2023-2028)
  • Table 268. Middle East Atracurium Sales, by Application K Units (2023-2028)
  • Table 269. Africa Atracurium Sales, by Type K Units (2023-2028)
  • Table 270. Africa Atracurium Sales, by Application K Units (2023-2028)
  • Table 271. North America Atracurium Sales, by Country K Units (2023-2028)
  • Table 272. North America Atracurium Sales, by Type K Units (2023-2028)
  • Table 273. North America Atracurium Sales, by Application K Units (2023-2028)
  • Table 274. United States Atracurium Sales, by Type K Units (2023-2028)
  • Table 275. United States Atracurium Sales, by Application K Units (2023-2028)
  • Table 276. Canada Atracurium Sales, by Type K Units (2023-2028)
  • Table 277. Canada Atracurium Sales, by Application K Units (2023-2028)
  • Table 278. Mexico Atracurium Sales, by Type K Units (2023-2028)
  • Table 279. Mexico Atracurium Sales, by Application K Units (2023-2028)
  • Table 280. Atracurium: by Type(USD/Units)
  • Table 281. Research Programs/Design for This Report
  • Table 282. Key Data Information from Secondary Sources
  • Table 283. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Atracurium: by Type USD Million (2017-2022)
  • Figure 5. Global Atracurium: by Application USD Million (2017-2022)
  • Figure 6. South America Atracurium Share (%), by Country
  • Figure 7. Asia Pacific Atracurium Share (%), by Country
  • Figure 8. Europe Atracurium Share (%), by Country
  • Figure 9. MEA Atracurium Share (%), by Country
  • Figure 10. North America Atracurium Share (%), by Country
  • Figure 11. Global Atracurium: by Type K Units (2017-2022)
  • Figure 12. Global Atracurium: by Application K Units (2017-2022)
  • Figure 13. South America Atracurium Share (%), by Country
  • Figure 14. Asia Pacific Atracurium Share (%), by Country
  • Figure 15. Europe Atracurium Share (%), by Country
  • Figure 16. MEA Atracurium Share (%), by Country
  • Figure 17. North America Atracurium Share (%), by Country
  • Figure 18. Global Atracurium: by Type USD/Units (2017-2022)
  • Figure 19. Global Atracurium share by Players 2022 (%)
  • Figure 20. Global Atracurium share by Players (Top 3) 2022(%)
  • Figure 21. Global Atracurium share by Players (Top 5) 2022(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 24. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 25. HOSPIRA (United States) Revenue, Net Income and Gross profit
  • Figure 26. HOSPIRA (United States) Revenue: by Geography 2022
  • Figure 27. Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China) Revenue, Net Income and Gross profit
  • Figure 28. Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China) Revenue: by Geography 2022
  • Figure 29. Jiangsu Hengrui Medicine (China) Revenue, Net Income and Gross profit
  • Figure 30. Jiangsu Hengrui Medicine (China) Revenue: by Geography 2022
  • Figure 31. Zhejiang Xianju Pharmaceutical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 32. Zhejiang Xianju Pharmaceutical Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 33. Joshi and Company (India) Revenue, Net Income and Gross profit
  • Figure 34. Joshi and Company (India) Revenue: by Geography 2022
  • Figure 35. Zhejiang Haisen Pharmaceutical Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 36. Zhejiang Haisen Pharmaceutical Co. Ltd. (China) Revenue: by Geography 2022
  • Figure 37. Aurobindo Pharma Limited (India) Revenue, Net Income and Gross profit
  • Figure 38. Aurobindo Pharma Limited (India) Revenue: by Geography 2022
  • Figure 39. Sagent Pharmaceuticals Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Sagent Pharmaceuticals Inc. (United States) Revenue: by Geography 2022
  • Figure 41. Alkaloids Corporation (India) Revenue, Net Income and Gross profit
  • Figure 42. Alkaloids Corporation (India) Revenue: by Geography 2022
  • Figure 43. Global Atracurium: by Type USD Million (2023-2028)
  • Figure 44. Global Atracurium: by Application USD Million (2023-2028)
  • Figure 45. South America Atracurium Share (%), by Country
  • Figure 46. Asia Pacific Atracurium Share (%), by Country
  • Figure 47. Europe Atracurium Share (%), by Country
  • Figure 48. MEA Atracurium Share (%), by Country
  • Figure 49. North America Atracurium Share (%), by Country
  • Figure 50. Global Atracurium: by Type K Units (2023-2028)
  • Figure 51. Global Atracurium: by Application K Units (2023-2028)
  • Figure 52. South America Atracurium Share (%), by Country
  • Figure 53. Asia Pacific Atracurium Share (%), by Country
  • Figure 54. Europe Atracurium Share (%), by Country
  • Figure 55. MEA Atracurium Share (%), by Country
  • Figure 56. North America Atracurium Share (%), by Country
  • Figure 57. Global Atracurium: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline Plc. (United Kingdom)
  • HOSPIRA (United States)
  • Dongying （Jiangsu） Pharmaceutical Industry Limited Company (China)
  • Jiangsu Hengrui Medicine (China)
  • Zhejiang Xianju Pharmaceutical Co., Ltd. (China)
  • Joshi and Company (India)
  • Zhejiang Haisen Pharmaceutical Co. Ltd. (China)
  • Aurobindo Pharma Limited (India)
  • Sagent Pharmaceuticals Inc. (United States)
  • Alkaloids Corporation (India)
Additional players considered in the study are as follows:
Biophore (India) , Sinoway Industrial Co. Ltd. (China) , Euticals S.p.a. (Italy) , Indukern (Spain)
Select User Access Type

Key Highlights of Report


Apr 2023 150 Pages 53 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Atracurium Market Quantitative research analysis
Global Atracurium Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Adoption of Atracurium in Healthcare Industry for Skeletal Muscle Relaxation " is seen as one of major growth factors of Atracurium Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Atracurium market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Atracurium Market Report?

Have a Query? Click Here

Other Related Reports

Cat Vaccines Comprehensive Study by Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Application (Vete...
$ 3750
Nattokinase Supplement Comprehensive Study by Type (Vegetarian, Contains gelatin), Application (For Cardiovascular Diseases, For Pain), Form (Capsules, Tablets, Liquid, Others), Distribution Channel ...
$ 3450
Herbal Weight Loss Products Comprehensive Study by Type (Tablet, Syrup, Supplements), Application (Fitness Centers, Online Sales, Pharmacies, Hyper Markets), Pills and Supplements (Garnicia Cambogia,...
$ 3450
Botulinum Toxin Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B, Others), Application (Cosmetic Applications, Therapeutic Applications), End User (Hospitals, Ambulatory Ca...
$ 3500
Bovine-based Collagen for Biomedical Applications Comprehensive Study by Application (Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs, Others), Major ...
$ 3750
Transdermal Drug Patches Comprehensive Study by Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patc...
$ 3750